Compare Injective (INJ) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Mira — how do they compare? Injective trades at Rp76,143 (market cap Rp7,62T, Rp1,22T 24h volume), while Mira trades at Rp700.06 (market cap Rp224,01M, Rp102,95M 24h volume). The key difference: Injective is far larger — about 34016.3× Mira's market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Mira for 22 Days on average.
| INJ | MIRA | |
|---|---|---|
Market Cap | Rp7,62T | Rp224,01M |
Volume (24h) | Rp1,22T | Rp102,95M |
Circulating Supply | 100M INJ | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 37 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
